Yehuda Chowers - Concepedia

Author

Yehuda Chowers

Also Known As

Chowers Y, Chowers, Yehuda, Horlander, John C., Michal Chowers, Tomoyuki Akiyama, Y CHOWERS, Y Chowers, Y. Chowers, Y. Chowers, YEHUDA CHOWERS

297

Publications

18.1K

Citations

H-Index

131

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University Rambam Health Care Campus Technion – Israel Institute of Technology Tel Aviv Sourasky Medical Center

About

Yehuda Chowers is an author at Sheba Medical Center specializing in medicine, immunology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	60	8K
2	Engineering	3	3	283
3	Health Sciences	2	2	23
4	Public Health	2	2	896
5	Natural Sciences	1	1	10

Yehuda Chowers

146

Publications

14.8K

Citations

H-Index

Page 1

	Year	Citations
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management Fernando Gomollón, Vito Annese, Herbert Tilg, Journal of Crohn s and Colitis Part 1GastroenterologyDiagnosisPathologyEuropean Evidence-based Consensus	2016	2K
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Jean‐François Rahier, Fernando Magro, Cândida Abreu, Journal of Crohn s and Colitis	2014	909
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis Rami Eliakim, Fernando Magro, Christian Maaser, Journal of Crohn s and Colitis Clinical PresentationGastroenterologyDiagnosisPathologyPopulation Health Sciences	2012	880
Development of the Crohnʼs disease digestive damage score, the Lémann score Benjamin Pariente, Jacques Cosnes, Silvio Danese, Inflammatory Bowel Diseases	2010	576
European evidence-based Consensus on the management of ulcerative colitis: Current management Simon Travis, Eduard F. Stange, M Lémann, Journal of Crohn s and Colitis RheumatologyAcute CareClinical EpidemiologyGastroenterologyDiagnosis	2008	557
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases Bella Ungar, Idan Levy, Yarden Yavne, Clinical Gastroenterology and Hepatology InflammationRheumatologyMucosal HealingAnti-inflammatoryAutoimmune Disease	2015	360
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects Matthieu Allez, Konstantinos Κarmiris, Édouard Louis, Journal of Crohn s and Colitis InflammationRheumatologyChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune Disease	2010	336
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab Henit Yanai, Lev Lichtenstein, Amit Assa, Clinical Gastroenterology and Hepatology Anti-inflammatoryAutoimmune DiseaseImmunologyTherapeutic EfficacyPharmacotherapy	2014	306
Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease Benjamin Pariente, Jean-Yves Mary, Silvio Danese, Gastroenterology Functional Gastrointestinal DisorderLémann IndexDiagnosisGastroenterologyPathology	2014	304
Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction Shiran Gerassy-Vainberg, Alexandra Blatt, Yael Danin‐Poleg, Gut	2017	304

Page 1